F-group (family)
5.1.4.257 FG-GAP, FG-GAP_3
Ligands and drugs
152
Member domains
119
with ligand contacts (≤ 4 Å)
78.3% of members
109
with DrugDomain annotations
71.7% of members
108
with a DrugBank compound
71.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.4.257 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 105 |
| DB06472 | MWX | Fradafiban | 4 |
| DB00775 | AGG | Tirofiban | 3 |
| DB00641 | — | — | 1 |
| DB01098 | — | Rosuvastatin | 1 |
| DB02618 | NDS | Ethyl Dimethyl Ammonio Propane Sulfonate | 1 |
| DB04863 | — | — | 1 |
| DB08860 | — | Pitavastatin | 1 |
| DB11611 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 117 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 39 |
| CL | CHLORIDE ION | 24 |
| AGG | TIROFIBAN | 4 |
| I1F | {5-[N-(4-carbamimidoylbenzoyl)-4-nitro-L-phenylalanyl]-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-2-yl}acetic acid | 4 |
| I7R | (4-{[(5S)-3-{4-[(E)-imino(4-methylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid | 4 |
| MGmetal | MAGNESIUM ION | 4 |
| MWX | Fradafiban | 4 |
| NB9 | Lamifiban | 4 |
| XQS | sibrafiban (active form) | 4 |
| 0DU | N-(2,6-dichlorobenzoyl)-4-[1,6-dimethyl-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl]-L-phenylalanine | 2 |
| 15P | POLYETHYLENE GLYCOL (N=34) | 2 |
| 5YB | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | 2 |
| IR7 | (4-{[2-oxo-4-(piperidin-4-yl)piperazin-1-yl]acetyl}phenoxy)acetic acid | 2 |
| M6K | (4-{[(5S)-3-(4-carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid | 2 |
| MJX | {4-[4-(4-carbamimidoylphenyl)piperazin-1-yl]piperidin-1-yl}acetic acid | 2 |
| MV8 | (4-{[(5R)-3-(4-carbamimidoylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}piperazin-1-yl)acetic acid | 2 |
| MWI | Lotrafiban | 2 |
| MWO | (4-{[(5S)-3-(piperidin-4-yl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid | 2 |
| N9U | Roxifiban | 2 |